DPT Laboratories Report issue

For profit Phase 3
Founded: San Antonio TX United States (1938)
Status: Acquired by Renaissance Pharma (2012)

Organization Overview

First Clinical Trial
2016
NCT03107611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

DPT Laboratories, Ltd.

Active Ingredients

Drugs in Phase 3 Trials (3)

azelaic acid (azelex) (1 trial)

econazole (spectazole) (1 trial)

pimecrolimus (elidel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Eczema (Phase 3)

Rosacea (Phase 3)

Tinea (Phase 3)

Tinea Pedis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3